---
title: "100 Healthtech Investors in New York: 88 in New York City"
last_updated: "2026-11-06"
rows: "100"
free_rows: "25"
source: "SEC filings"
canonical: "https://theinvestordatabase.com/lists/healthtech-investors-in-new-york/"
---

# 100 healthtech investors in New York, including 88 in New York City

We list 100 healthtech investors in New York as of November 2026: each has an SEC filing on file, and the list was last checked on 6 Nov 2026. The cities with the most head offices on this list are New York (82), Brooklyn (6) and Ithaca (1). 88 of the 100 are in the New York City metro area, so this page is also our list of healthtech investors in New York City.

- 100 investors
- 68 with a fund filing or dated deal in the last 12 months
- $78M median fund size on file (SEC Form D, 72 firms)
- 543 named decision-makers on file

## First 25 of 100 healthtech investors in New York

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| Digitalis Ventures | VC firm | New York, NY | Seed | Healthtech, Biotech, Medtech | Portfolio news, Nov 2026 | $862M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/digitalis-ventures/ |
| Inspired | VC firm | New York, NY | Seed | Healthtech, AI, Fintech, Generalist | New fund, Oct 2026 | $450M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/inspired/ |
| Greycroft | VC firm | New York, NY | Series A, Series B, Growth | Healthtech, AI, Industrial Tech, Defense Tech | New deal, Oct 2026 | $600M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/greycroft/ |
| Left Lane Capital | VC firm | Brooklyn, NY |  | Healthtech, AI, Fintech, Logistics | New deal, Aug 2026 | $599M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/left-lane-capital/ |
| Alpha Partners | VC firm | New York, NY | Series B, Growth | Healthtech, AI, Developer Tools, Cybersecurity | New fund, Oct 2026 | $200M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/alpha-partners/ |
| Town Hall Ventures | VC firm | New York, NY | Growth | Healthtech, Impact, Medtech | New deal, Sep 2026 | $400M (SEC Form D, 2025) | 2026-11-05 | https://theinvestordatabase.com/investors/town-hall-ventures/ |
| 1540 Ventures | VC firm | New York, NY |  | Healthtech, Medtech | New fund, Oct 2026 | $50M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/1540-ventures/ |
| Great Oaks Venture Capital | VC firm | New York, NY | Pre-seed, Seed, Series A | Healthtech, Generalist, SaaS, Fintech | Portfolio news, Sep 2026 | $20M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/great-oaks-venture-capital/ |
| Ansa | VC firm | New York, NY | Series A, Series B, Growth | Healthtech, AI, Cybersecurity, Media | New fund, May 2026 | $200M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/ansa/ |
| Avid Ventures | VC firm | New York, NY | Pre-seed | Healthtech, AI, Fintech, SaaS | Portfolio news, Oct 2026 | $75M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/avid-ventures/ |
| Kalos Ventures | VC firm | Brooklyn, NY | Seed, Series A | Healthtech, Future of Work, Edtech, Hardware | New deal, Aug 2026 | $75M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/kalos-ventures/ |
| Lux Ventures | VC firm | New York, NY |  | Healthtech, AI, Mobility, Media | New fund, Sep 2026 | $1.5B (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/lux-ventures/ |
| RH NV | VC firm | New York, NY | Any stage | Healthtech, AI, Edtech, Medtech | New deal, Oct 2026 | $279M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/rh-nv/ |
| Quartus | VC firm | New York, NY | Growth | Healthtech, AI, B2B, Edtech | New fund, Sep 2026 | $150M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/quartus/ |
| Chloe Capital | VC firm | Ithaca, NY | Seed | Healthtech, AI, Impact, Edtech | New fund, Jul 2026 | $10M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/chloe-capital/ |
| Imaginary Venture Capital | VC firm | New York, NY |  | Healthtech, Logistics, AI, Consumer | New fund, Feb 2026 | $500M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/imaginary-venture-capital/ |
| Preface Ventures | VC firm | New York, NY | Pre-seed, Seed, Series A | Healthtech, Fintech, Future of Work, B2B | New fund, Sep 2026 | $57M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/preface-ventures/ |
| Meridian Street | VC firm | New York, NY | Pre-seed | Healthtech, AI, Fintech, Logistics | New fund, Aug 2026 | $85M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/meridian-street/ |
| 25Madison Ventures | VC firm | New York, NY | Pre-seed, Seed, Series A | Healthtech, AI, Logistics, Industrial Tech | New fund, Oct 2026 | $50M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/25madison-ventures/ |
| Antler | Accelerator | New York, NY | Pre-seed, Seed, Series A, Series B, Growth | Healthtech, AI, Biotech, Consumer | New deal, Aug 2026 | $90M (SEC Form D, 2023) | 2026-11-04 | https://theinvestordatabase.com/investors/antler/ |
| Colle Capital | VC firm | New York, NY | Seed | Healthtech, AI, Fintech, Logistics | New fund, Jun 2026 | $72M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/colle-capital/ |
| Ghic | VC firm | New York, NY |  | Healthtech, Biotech, Impact, Medtech | New fund, May 2026 | $270M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/ghic/ |
| Flybridge | VC firm | New York, NY | Pre-seed, Seed | Healthtech, AI, Developer Tools, Logistics | New fund, Dec 2025 | $110M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/flybridge/ |
| Arcventis Health Partners | VC firm | New York, NY | Growth | Healthtech, Biotech, Medtech | New fund, Sep 2026 | $33M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/arcventis-health-partners/ |
| NVP Capital | VC firm | New York, NY | Pre-seed, Seed | Healthtech, AI, Fintech, Industrial Tech | New fund, Oct 2026 | $16M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/nvp-capital/ |

You are seeing 25 of 100. The full list adds 75 more investors and 543 named decision-makers.

Get all 100 investors and 543 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/healthtech-investors-in-new-york
This page: https://theinvestordatabase.com/lists/healthtech-investors-in-new-york/

## 88 healthtech investors in New York City
60 of the 88 have a fund filing or a dated deal in the last 12 months; the median fund size on file is $90M (SEC Form D, 65 firms); the most recent fund filings are from 25Madison Ventures (Oct 2026), Inspired (Oct 2026) and Alpha Partners (Oct 2026); of the 70 with a stage on file, seed (39), pre-seed (33) and growth-stage (20); the count covers the metro area, by city: New York (82) and Brooklyn (6); the paid file holds 484 named decision-makers for them.
The first 5 in list order: Digitalis Ventures, Inspired, Greycroft, Left Lane Capital and Alpha Partners.

## Method and limits
- Source: All 100 rows carry an SEC filing (Form D or Form ADV). All 100 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states healthtech and digital health as a focus on its own site, or we observed it in the firm's portfolio. Place: head office in New York.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stated focus on the US (15: full marks when the firm names the US as where it invests, half when it says global), size of the fund on file on a log scale (15) and completeness of the public record (10). Regional focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 100 rows: stage 82, sector 100, fund size 88, website 100. In the paid file: named decision-makers on 98 rows, firm email on 33, LinkedIn page on 54, check size on 7.

## Questions
### How many healthtech investors in New York are there?
We list 100 as of November 2026. 68 of the 100 have a fund filing or a dated deal in the last 12 months. The cities with the most are New York (82), Brooklyn (6) and Ithaca (1).

### Which healthtech investors in New York raised a new fund in the last 12 months?
49 of the 100 have a fund filing dated in the last 12 months. The most recent on this list are 25Madison Ventures (Oct 2026), Inspired (Oct 2026) and Overlap Holdings (Oct 2026).

### What is the typical fund size of healthtech investors in New York?
The median fund size on file for this list is $78M, across the 72 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 28 do not disclose a size there.

### How do I contact healthtech investors in New York?
The paid file holds 543 named decision-makers across 98 of these 100 and a firm email for 33. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.

### Where does the data on healthtech investors in New York come from?
All 100 rows have an SEC filing on file (Form D or Form ADV). Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 6 Nov 2026 at the latest. The whole file is re-verified twice a year.